Title : [Analysis of neoadjuvant docetaxel, carboplatin and trastuzumab (TCH) in HER-2-positive breast cancer].

Pub. Date : 2018 Mar 27

PMID : 29665663






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 [Analysis of neoadjuvant docetaxel, carboplatin and trastuzumab (TCH) in HER-2-positive breast cancer]. thiocarbohydrazide erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 The data of patients with HER-2 positive conducted TCH neoadjuvant therapy and surgery, and with the complete clinicopathological information were analyzed. thiocarbohydrazide erb-b2 receptor tyrosine kinase 2 Homo sapiens
3 Conclusion: TCH is an effective neoadjuvant therapy for patients with HER-2 positive breast cancer, and the toxic and side effects were under control. thiocarbohydrazide erb-b2 receptor tyrosine kinase 2 Homo sapiens